Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

Delayed Data
As of Aug 28
 +1.22 / +0.52%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Valeant Pharmaceuticals have a median target of 290.00, with a high estimate of 304.00 and a low estimate of 219.85. The median estimate represents a +22.82% increase from the last price of 236.12.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Buy stock in Valeant Pharmaceuticals. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.80%
Growthannually 38.91%


Growthquarterly 1.54%
Growthannually 32.76%
Key to the earnings and sales forecast charts.